Automated Cell Biology Systems Market is likely to register CAGR of 9.0% through 2032

With a market share of 89.8% in all of North America in 2021, the USA presently dominates the region and is expected to sustain this growth throughout the forecast period.

According to the most recent industry study from Future Market Insights, the global Automated Cell Biology Systems Market sales is valued at US$ 14.1 billion in 2022 and is estimated to grow at a CAGR of close to 9.0% over the forecast period, reaching a value of roughly US$ 33.5 billion in 2032.

Laboratory automation, a major force in the biotechnology sector, enables the creation of strong new technologies and applications. Automation in research and production, particularly in personalised therapeutics, is required to achieve cost effectiveness and widespread accessibility of customised treatments.

Over the last two decades, the biotechnology industry has placed an increasing emphasis on laboratory automation. With the advancement of digitalization and Industry 4.0, biotech automation has expanded from its initial concentration on analytical laboratories to being widely used throughout the industry.

Request a Sample to Obtain Analysis and Comprehensive Market Insights@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15816

Indeed, it is commonly understood that many areas of future medicine will be impossible to achieve without the assistance of automation. These include complex data processing automation for precision medicine, healthcare robotics for surgery and care, automated manufacturing, and sophisticated supply chains for new treatments.

This is especially true for personalised cell-based treatments, which rely on automation to reduce prices and boost accessibility. Patient-derived cell multiplication is labor-intensive and characterised by significant batch-to-batch variability, whether for personalised drug research or autologous cell therapy.

Furthermore, because individual batch sizes are small, personalised medication necessitates a high overall throughput to be financially viable. These factors drive demand for Automated Cell Biology Systems, boosting the market's overall value over the forecast period.

Key Takeaways from Market Study

• Because they deliver reliable cell counts, automated cell counters (single function) are the leading product group, accounting for roughly 34.6% of the market in 2021.
• Drug development applications will have a market share of roughly 35.4% in 2021, owing to the biopharmaceutical industry's rapid growth.
• Because infinite cell line cultures are easier to culture than primary cell cultures, they will account for around 76.2% in 2021.
• Because of expanding CMO/CDMO activities for drug production, biopharmaceutical companies will hold a share of roughly 27.4% in 2021.
• North America has a dominant share of 37.4% in 2021, owing to the region's high economic output.

“Rising Demand for Personalized Medicine, and Growth in Total Lab Automation Techniques will Propel Overall Market Growth,”says an analyst of Future Market Insights.

For critical insights on this market, request to ask an expert@ https://www.futuremarketinsights.com/ask-question/rep-gb-15816

Market Competition

Key Players:

• Thermo Fisher Scientific
• Corning Incorporated
• Merck KGaA
• Lonza
• Sartorius AG
• Hitachi. Ltd
• Nanoentek
• ChemoMetec
• Danaher corporation
• Others

Automated cell biology system manufacturers have been substantially investing in research to offer long-term solutions for both the biopharmaceutical and packaging industries. Players in the Automated Cell Biology Systems market are also focusing on innovations and alliances to strengthen their market position.

For instance:

• In October 2022, Thermo Fisher developed a closed and automated cell separation and bead removal system to aid in the advancement of cell therapy manufacturing.
• Merck will expand bioprocessing capabilities by purchasing Lonza's MAST® Platform, a prominent automated bioreactor sampling technology, in April 2022.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the Automated Cell Biology Systems market in its latest study, presenting a historical demand assessment of 2012 to 2021 and projections for 2022 to 2032. The global Automated Cell Biology Systems market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

For in-depth competitive analysis, Buy Now@ https://www.futuremarketinsights.com/checkout/15816

Key Market Segments Covered in Automated Cell Biology Systems Industry Research

By Product:

• Cell Culture Process Automatization Instrument or Robot (Multiple Function)
• Automated Bioreactor (Single or Multiple Function)
• Automated Cell Culture Media Exchange System (Single Function)
• Automated Culture Media Analyzer (Single Function)
• Automated Cell Wash-and-Concentrate System (Single Function)
• Automated Cell Counter (Single Function)
• Automated Fill And Finish System (Single Function)
• Automated Cell Storage Equipment (Single Function)
• Management Software

By Cell Culture:

• Finite Cell Line Cultures
• Infinite Cell Line Cultures

By Application:

• Cell Therapy
• Drug Development
• Stem Cell Research
• Regenerative Medicine

By End User:

• Mega Pharmaceutical companies
• Biopharmaceutical companies
• CDMOs/CMOs
• Research organizations
• Academic institutes